Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-19

FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Cadila Pharmaceuticals' original application for a generic donepezil hydrochloride product for the treatment of Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

ORIG AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)